Innovative Research for Thrombosis and Embolism

The physicians and researchers at the University of Chicago Medicine have a long history of pioneering medical breakthroughs and innovative treatments. We continue that legacy as our scientists and physicians work together to transforms basic and translational research into bedside care for patients with venous thromboembolism (VTE).  

Continued Improvements for Treatment

Due to the fact that our multidisciplinary team includes experts in a wide range of specialties, we are fortunate to have physician-scientists devoted to comprehensive thrombosis and embolism research.

Today, UChicago Medicine’s interventional cardiologists are conducting clinical research projects aimed at understanding indications for invasive therapies, developing new tools to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and exploring the use of new blood thinning medications. 

Additionally, our radiologists are committed to improving care for patients with DVT and PE. Because we understand that standard interventional approaches may not be effective for older, chronic thrombi, we investigate alternative treatment options. Dr. Kenneth Bader is working on therapies using focused ultrasound waves in combination with standard treatment methods. His research uses thrombolytic recombinant tissue plasminogen activator (tPA) acting synergistically with histotripsy pulses to provide enhanced thrombolysis in a highly retracted venous clot in vitro. Dr. Bader is also developing targeted ablation methods to improve thrombolysis in the treatment of currently intractable deep vein thrombosis.

Ongoing Advancements in Clinical Trials

At UChicago Medicine, we are constantly evolving care through our clinical trials which provide our patients with access to new, advanced treatments before they are available to the public.

Currently, our team has several active clinical trials that offer patients innovative solutions to venous thromboembolism. Contact your physician to learn more about participating in one of our trials.